Successful treatment of AML using non-intensive chemotherapy in Jehovah's Witness patients
{{output}}
Acute myeloid leukemia (AML) patients undergoing induction chemotherapy receive transfusion support to manage severe cytopenias and associated sequelae. Jehovah's Witness (JW) patients typically decline transfusion of most or all blood products. This can lead ... ...
